Van Naarden Jacob
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Van Naarden Jacob. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LLY | EVP & Pres., Lilly Oncology | Purchase | 1,000 | $647.36 | $647,360 | Aug 13, 2025 |
| LLY | EVP & Pres., Lilly Oncology | Award / Grant | 6,104 | $868.88 | $5,303,487 | Feb 10, 2025 |
| LLY | EVP & Pres., Lilly Oncology | Tax Withholding | 1,410 | $811.08 | $1,143,493 | Feb 1, 2025 |
| LLY | EVP & Pres., Lilly Oncology | Gift | 4,302 | — | — | Oct 31, 2024 |
| LLY | EVP & Pres., Loxo@Lilly | Award / Grant | 2,369 | $737.26 | $1,746,569 | Feb 12, 2024 |
| LLY | EVP & Pres., Loxo@Lilly | Option Exercise | 3,618 | — | — | Feb 1, 2024 |
| LLY | EVP and CEO Loxo@Lilly | Tax Withholding | 1,314 | $335.01 | $440,203 | Feb 16, 2023 |
| LLY | EVP and CEO Loxo@Lilly | Award / Grant | 2,407 | $345.12 | $830,704 | Feb 10, 2023 |
| LLY | SVP, CEO LoxoONC, Pres LlyONC | Option Exercise | 5,461 | — | — | Feb 16, 2022 |
| 0001581720 | Chief Operating Officer | Disposition | 19,000 | $235.00 | $4,465,000 | Feb 15, 2019 |
| 0001581720 | Chief Business Officer | Sale | 400 | $130.59 | $52,236 | Dec 10, 2018 |
| 0001581720 | Chief Business Officer | Sale | 300 | $147.06 | $44,118 | Nov 27, 2018 |
| 0001581720 | Chief Business Officer | Option Exercise | 5,500 | $3.65 | $20,075 | Oct 3, 2018 |
| 0001581720 | Chief Business Officer | Sale | 1,500 | $166.63 | $249,945 | Sep 12, 2018 |
| 0001581720 | Chief Business Officer | Sale | 3,070 | $158.66 | $487,086 | Aug 14, 2018 |
| 0001581720 | Chief Business Officer | Sale | 680 | $178.39 | $121,305 | Jul 9, 2018 |
| 0001581720 | Chief Operating Officer | Option Exercise | 1,541 | $3.65 | $5,625 | Jul 9, 2018 |
| 0001581720 | Chief Business Officer | Sale | 100 | $178.23 | $17,823 | Jun 20, 2018 |
| 0001581720 | Chief Business Officer | Sale | 241 | $134.25 | $32,354 | May 15, 2018 |
| 0001581720 | Chief Business Officer | Sale | 541 | $132.05 | $71,439 | Apr 24, 2018 |
| 0001581720 | Chief Business Officer | Sale | 646 | $132.02 | $85,285 | Mar 13, 2018 |
| 0001581720 | Chief Business Officer | Option Exercise | 1,541 | $3.65 | $5,625 | Feb 13, 2018 |
| 0001581720 | Chief Business Officer | Sale | 446 | $86.30 | $38,490 | Jan 17, 2018 |
| 0001581720 | Chief Business Officer | Sale | 400 | $77.60 | $31,040 | Dec 14, 2017 |
| 0001581720 | Chief Business Officer | Sale | 600 | $73.27 | $43,962 | Nov 27, 2017 |
| 0001581720 | Chief Business Officer | Sale | 400 | $86.95 | $34,780 | Oct 30, 2017 |
| 0001581720 | Chief Business Officer | Option Exercise | 1,541 | $3.65 | $5,625 | Sep 18, 2017 |
| 0001581720 | Chief Business Officer | Sale | 541 | $74.07 | $40,072 | Aug 14, 2017 |